Literature DB >> 35324265

Prevalence of Alzheimer's and Related Dementia Diseases and Risk Factors Among Transgender Adults, Florida, 2012‒2020.

Yi Guo1, Qian Li1, Xi Yang1, Michael S Jaffee1, Yonghui Wu1, Fei Wang1, Jiang Bian1.   

Abstract

Objectives. To estimate the prevalence rates of Alzheimer's disease and related dementias (ADRD) and their risk factors in the transgender population and compare the rates to those in cisgender adults. Methods. We identified 1784 transgender adults in the linked electronic health records and claims data between 2012 and 2020 from the OneFlorida Clinical Research Consortium. We calculated the prevalence of ADRD and ADRD risk factors for the transgender and matched cisgender control adults. Results. The prevalence of ADRD was higher in the transgender adults compared with the cisgender control adults. Overall, the prevalence of ADRD risk factors was significantly higher in the transgender adults than the cisgender controls for 11 out of the 13 risk factors, with the only exceptions being traumatic brain injury and visual impairment. Conclusions. Transgender adults are at significantly higher risk for ADRD than cisgender adults. Our study highlights the urgent need for more research on the unique ADRD risks among the aging transgender and larger sexual- and gender-minority populations. (Am J Public Health. 2022;112(5):754-757. https://doi.org/10.2105/AJPH.2022.306720).

Entities:  

Mesh:

Year:  2022        PMID: 35324265      PMCID: PMC9010917          DOI: 10.2105/AJPH.2022.306720

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  9 in total

Review 1.  Meta-analysis of modifiable risk factors for Alzheimer's disease.

Authors:  Wei Xu; Lan Tan; Hui-Fu Wang; Teng Jiang; Meng-Shan Tan; Lin Tan; Qing-Fei Zhao; Jie-Qiong Li; Jun Wang; Jin-Tai Yu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-08-20       Impact factor: 10.154

2.  Developing and Validating a Computable Phenotype for the Identification of Transgender and Gender Nonconforming Individuals and Subgroups.

Authors:  Yi Guo; Xing He; Tianchen Lyu; Hansi Zhang; Yonghui Wu; Xi Yang; Zhaoyi Chen; Merry Jennifer Markham; François Modave; Mengjun Xie; William Hogan; Christopher A Harle; Elizabeth A Shenkman; Jiang Bian
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

Review 3.  Global health burden and needs of transgender populations: a review.

Authors:  Sari L Reisner; Tonia Poteat; JoAnne Keatley; Mauro Cabral; Tampose Mothopeng; Emilia Dunham; Claire E Holland; Ryan Max; Stefan D Baral
Journal:  Lancet       Date:  2016-06-17       Impact factor: 79.321

4.  Transgender Medicare Beneficiaries and Chronic Conditions: Exploring Fee-for-Service Claims Data.

Authors:  Christina N Dragon; Paul Guerino; Erin Ewald; Alison M Laffan
Journal:  LGBT Health       Date:  2017-11-10       Impact factor: 4.151

5.  2021 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2021-03-23       Impact factor: 21.566

6.  From Brain Disease to Brain Health: Primary Prevention of Alzheimer's Disease and Related Disorders in a Health System Using an Electronic Medical Record-Based Approach.

Authors:  A M Fosnacht; S Patel; C Yucus; A Pham; E Rasmussen; R Frigerio; S Walters; D Maraganore
Journal:  J Prev Alzheimers Dis       Date:  2017

7.  Patient-powered research networks: building capacity for conducting patient-centered clinical outcomes research.

Authors:  Sarah E Daugherty; Sarita Wahba; Rachael Fleurence
Journal:  J Am Med Inform Assoc       Date:  2014-05-12       Impact factor: 4.497

Review 8.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.

Authors:  Gill Livingston; Jonathan Huntley; Andrew Sommerlad; David Ames; Clive Ballard; Sube Banerjee; Carol Brayne; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Sergi G Costafreda; Amit Dias; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Mika Kivimäki; Eric B Larson; Adesola Ogunniyi; Vasiliki Orgeta; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam
Journal:  Lancet       Date:  2020-07-30       Impact factor: 79.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.